CN Stock MarketDetailed Quotes

300436 Fujian Cosunter Pharmaceutical

Watchlist

30.05
+0.66+2.25%

Market Closed Apr 30 15:00 CST

4.79BMarket Cap-28.14P/E (TTM)

Fujian Cosunter Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

Assets

Current assets

Money funds

-41.26%119.51M

-29.03%143.95M

-39.00%127.35M

-54.26%131.09M

-38.23%203.46M

-15.12%202.83M

-30.38%208.75M

-4.50%286.57M

-9.23%329.41M

-39.28%238.98M

Notes receivable and accounts receivable

-4.37%66.86M

0.88%68.14M

41.89%62.33M

60.77%65.79M

61.00%69.92M

42.94%67.54M

-13.86%43.93M

-14.69%40.92M

-18.06%43.43M

-12.01%47.25M

-Notes receivable

----

--0

----

-Accounts receivable

-4.37%66.86M

0.88%68.14M

41.89%62.33M

60.77%65.79M

61.00%69.92M

42.94%67.54M

-13.03%43.93M

-13.26%40.92M

-12.90%43.43M

-8.57%47.25M

Other receivables (including interest and dividends)

-16.18%1.34M

188.16%4.29M

5.82%1.48M

25.22%1.54M

27.11%1.6M

5.20%1.49M

-46.72%1.4M

-52.50%1.23M

-50.73%1.26M

-42.60%1.41M

-Other receivable

----

25.22%1.54M

----

5.20%1.49M

----

-52.50%1.23M

----

-42.60%1.41M

Advance payment

-58.85%7.03M

-15.95%14.36M

-16.64%15.23M

33.74%16.43M

-50.98%17.09M

216.59%17.09M

350.33%18.27M

177.80%12.29M

638.24%34.86M

-9.26%5.4M

Inventories

-6.15%121.13M

2.69%114.48M

13.36%145.62M

3.73%110.66M

62.13%129.07M

62.36%111.48M

77.19%128.46M

36.50%106.68M

2.73%79.61M

-16.06%68.66M

Receivable financing

492.29%2.28M

3.54%2.29M

-49.07%843.48K

-25.96%354.27K

-68.35%385.78K

207.10%2.21M

--1.66M

--478.48K

--1.22M

28.59%721.14K

Non-current assets due within one year

----

--128.3K

----

Other current assets

30.89%59.89M

27.91%59.67M

58.10%77.46M

58.83%76.28M

24.87%45.76M

46.33%46.65M

92.82%49M

119.77%48.03M

179.14%36.64M

169.06%31.88M

Total current assets

-19.10%378.05M

-9.35%407.3M

-4.68%430.32M

-18.95%402.15M

-11.23%467.28M

13.95%449.29M

-0.87%451.46M

9.04%496.2M

2.45%526.42M

-28.29%394.3M

Non Current assets

Long-term equity investment

-11.65%79.1M

-26.32%80.18M

-43.38%87.18M

-43.86%89.15M

-45.48%89.53M

-36.27%108.81M

-1.30%153.98M

10.66%158.82M

38.23%164.2M

70.78%170.74M

Fixed assets

----

9.26%590.08M

----

14.11%609.13M

----

29.82%540.06M

----

47.38%533.8M

Constru in process

----

-73.32%26.99M

----

-40.99%29.86M

----

-38.77%101.13M

----

-65.63%50.6M

Intangible assets

-12.56%246.28M

-13.84%251.66M

161.83%278.98M

161.29%287.81M

195.85%281.66M

189.66%292.08M

0.09%106.55M

-1.37%110.15M

-15.30%95.21M

-15.22%100.83M

Development expenditure

-93.43%411.68K

16.66%5.84M

-96.54%5.72M

-96.08%5.69M

-90.19%6.27M

-76.67%5M

685.38%165.26M

600.57%145.18M

148.95%63.88M

-15.15%21.45M

Goodwill

0.00%58.97M

Long deferred expense

-13.58%35.66M

-13.58%36.94M

-11.34%38.56M

-7.88%39.79M

10.12%41.26M

26.57%42.75M

36.97%43.49M

98.40%43.19M

265.81%37.47M

364.14%33.77M

Deferred tax assets

-38.41%1.46M

27.13%1.47M

-95.49%2.33M

-95.31%2.37M

-97.13%2.37M

-98.37%1.15M

-0.26%51.62M

1.47%50.58M

62.35%82.57M

65.02%71.07M

Usufruct assets

-43.87%219.67K

-25.56%370.76K

41.93%521.85K

49.59%432.94K

9.53%391.38K

17.13%498.08K

202.48%367.67K

177.59%289.42K

128.48%357.33K

103.92%425.23K

Other non current assets

-50.14%8.56M

-52.40%8.06M

-73.79%8.92M

-76.21%8.43M

-75.37%17.18M

-71.23%16.94M

-30.39%34.04M

-33.58%35.44M

85.54%69.73M

74.48%58.87M

Total non current assets

-10.72%1B

-11.47%1.03B

-12.98%1.08B

-10.78%1.11B

-5.62%1.13B

5.87%1.17B

18.26%1.25B

19.46%1.24B

21.79%1.19B

22.71%1.1B

Total assets

-13.18%1.38B

-10.88%1.44B

-10.77%1.51B

-13.11%1.51B

-7.34%1.59B

8.00%1.61B

12.48%1.7B

16.29%1.74B

15.13%1.72B

3.32%1.49B

Liabilities

Current liabilities

Short term loan

-32.79%172.19M

-16.88%182.18M

6.98%229.21M

-6.78%207.23M

36.83%256.21M

4.73%219.18M

10.32%214.25M

68.24%222.31M

68.79%187.25M

169.15%209.27M

Notes payable and accounts payable

-9.91%187.92M

-5.78%213.84M

51.49%227.52M

31.46%197.44M

95.82%208.59M

139.02%226.96M

91.41%150.19M

84.41%150.2M

22.56%106.53M

11.02%94.96M

-Notes payable

----

71.43%600K

-57.39%600K

----

-89.33%350K

-62.46%1.41M

-40.53%1.56M

-20.35%1.84M

-Accounts payable

-9.91%187.92M

-5.78%213.84M

51.44%226.92M

32.30%196.84M

98.72%208.59M

143.74%226.96M

99.29%149.84M

91.50%148.79M

24.52%104.97M

11.89%93.12M

Contract liabilities

-15.19%5.66M

-70.05%3.57M

-66.39%5.1M

-27.98%6.78M

6.89%6.68M

44.81%11.91M

189.31%15.18M

68.23%9.41M

-19.78%6.25M

24.02%8.22M

Advance receipts

75.00%6.74K

0.00%5.78K

----

0.00%1.93K

0.00%3.85K

--5.78K

----

--1.93K

--3.85K

----

Salaries payable

-6.42%5.77M

-25.94%11.67M

-8.00%9.64M

-17.10%6.66M

0.44%6.17M

16.02%15.76M

19.07%10.47M

20.51%8.03M

37.38%6.14M

28.27%13.58M

Taxs payable

-6.94%6.63M

15.13%8.65M

6.56%8.22M

-6.23%6.32M

-1.39%7.12M

-55.57%7.51M

-67.35%7.71M

-67.16%6.74M

-56.61%7.22M

16.50%16.91M

Other payable (including interest and dividends)

-11.51%35.12M

-14.31%36.52M

-29.19%33.1M

-17.28%37.17M

-6.36%39.69M

-8.46%42.62M

9.01%46.74M

10.98%44.93M

-1.51%42.38M

5.90%46.56M

-Other payable

----

-17.28%37.17M

----

-8.46%42.62M

----

10.98%44.93M

----

5.90%46.56M

Non current liabilities due within one year

112.90%134.2M

63.22%118.02M

52.60%32.38M

184.93%60.4M

162.71%63.03M

298.72%72.3M

-65.46%21.22M

-65.50%21.2M

-61.65%23.99M

-71.02%18.13M

Other current liabilities

-23.77%573.66K

-78.43%326.54K

-63.83%590.83K

-8.63%809.49K

15.40%752.56K

66.29%1.51M

141.51%1.63M

51.51%885.93K

-43.19%652.14K

21.54%910.28K

Total current liabilities

-6.83%548.08M

-3.85%574.78M

16.77%545.75M

12.75%522.81M

54.63%588.25M

46.31%597.76M

12.54%467.39M

32.91%463.7M

14.07%380.42M

35.14%408.55M

Current liabilities

Long term loan

-16.01%139.71M

-15.10%142.36M

-17.66%182.64M

-23.16%169.19M

-10.25%166.34M

99.54%167.69M

562.12%221.81M

489.51%220.18M

329.52%185.34M

78.80%84.04M

Estimate liabilities

----

--1.04M

----

--608.24K

--1.26M

--1.79M

Deferred tax liabilities

11.40%2.66M

11.77%2.67M

11.35%2.36M

13.64%2.44M

4.01%2.39M

-1.36%2.38M

12.93%2.12M

11.50%2.15M

-72.30%2.3M

17.99%2.42M

Long term deferred income

68.26%65.71M

65.00%65.99M

-6.56%37.18M

-6.40%38.11M

-4.23%39.05M

-5.52%39.99M

-5.95%39.79M

-5.92%40.72M

-8.01%40.78M

-7.09%42.33M

Lease liabilities

----

447.44%554K

-4.76%94.87K

--50.07K

----

--101.2K

--99.61K

Other non current liabilities

7.38%259.6M

7.54%255.2M

7.69%250.7M

7.84%246.2M

7.99%241.76M

--237.31M

--232.81M

--228.31M

--223.86M

----

Total non current liabilities

3.91%467.69M

4.42%467.25M

-4.89%472.88M

-7.32%455.95M

-0.78%450.09M

242.44%447.47M

539.99%497.19M

495.94%491.96M

373.66%453.63M

38.12%130.67M

Total liabilities

-2.18%1.02B

-0.31%1.04B

5.60%1.02B

2.42%978.75M

24.49%1.04B

93.84%1.05B

95.66%964.58M

121.51%955.67M

94.29%834.06M

35.85%539.22M

Shareholders equity

Paid-in capital

0.00%159.27M

0.31%159.27M

Capital reserve funds

0.00%607.93M

-0.62%607.93M

-9.44%607.93M

-9.58%607.93M

-9.02%611.69M

-7.22%611.69M

1.82%671.32M

Surplus reserve funds

0.00%44.39M

Retained profit

-54.93%-479.9M

-52.97%-451.41M

-156.95%-365.74M

-219.23%-331.14M

-3,053.33%-309.75M

-651.74%-295.1M

-230.11%-142.34M

-167.07%-103.73M

-105.72%-9.82M

-70.43%53.49M

Shareholders equity without minority interests

-33.91%331.69M

-30.26%360.18M

-33.38%445.84M

-32.49%480.45M

-37.70%501.84M

-44.37%516.48M

-32.08%669.25M

-30.96%711.62M

-22.11%805.53M

-11.01%928.46M

Minority interests

-32.51%35.56M

-30.63%36.6M

-21.25%49.64M

-27.57%52.68M

-33.74%52.7M

94.26%52.76M

108.89%63.04M

113.13%72.73M

168.37%79.53M

318.59%27.16M

Total shareholder equity

-33.77%367.25M

-30.30%396.78M

-32.34%495.49M

-32.03%533.12M

-37.34%554.54M

-40.43%569.24M

-27.89%732.29M

-26.34%784.35M

-16.81%885.06M

-8.97%955.62M

Total liabilityies and equity

-13.18%1.38B

-10.88%1.44B

-10.77%1.51B

-13.11%1.51B

-7.34%1.59B

8.00%1.61B

12.48%1.7B

16.29%1.74B

15.13%1.72B

3.32%1.49B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Beijing Dehao International Accounting Firm (Special General Partnership)

Dahua Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022
Assets
Current assets
Money funds	-41.26%119.51M	-29.03%143.95M	-39.00%127.35M	-54.26%131.09M	-38.23%203.46M	-15.12%202.83M	-30.38%208.75M	-4.50%286.57M	-9.23%329.41M	-39.28%238.98M
Notes receivable and accounts receivable	-4.37%66.86M	0.88%68.14M	41.89%62.33M	60.77%65.79M	61.00%69.92M	42.94%67.54M	-13.86%43.93M	-14.69%40.92M	-18.06%43.43M	-12.01%47.25M
-Notes receivable	----	----	----	----	--0	----	----	----	----	----
-Accounts receivable	-4.37%66.86M	0.88%68.14M	41.89%62.33M	60.77%65.79M	61.00%69.92M	42.94%67.54M	-13.03%43.93M	-13.26%40.92M	-12.90%43.43M	-8.57%47.25M
Other receivables (including interest and dividends)	-16.18%1.34M	188.16%4.29M	5.82%1.48M	25.22%1.54M	27.11%1.6M	5.20%1.49M	-46.72%1.4M	-52.50%1.23M	-50.73%1.26M	-42.60%1.41M
-Other receivable	----	----	----	25.22%1.54M	----	5.20%1.49M	----	-52.50%1.23M	----	-42.60%1.41M
Advance payment	-58.85%7.03M	-15.95%14.36M	-16.64%15.23M	33.74%16.43M	-50.98%17.09M	216.59%17.09M	350.33%18.27M	177.80%12.29M	638.24%34.86M	-9.26%5.4M
Inventories	-6.15%121.13M	2.69%114.48M	13.36%145.62M	3.73%110.66M	62.13%129.07M	62.36%111.48M	77.19%128.46M	36.50%106.68M	2.73%79.61M	-16.06%68.66M
Receivable financing	492.29%2.28M	3.54%2.29M	-49.07%843.48K	-25.96%354.27K	-68.35%385.78K	207.10%2.21M	--1.66M	--478.48K	--1.22M	28.59%721.14K
Non-current assets due within one year	----	--128.3K	----	----	----	----	----	----	----	----
Other current assets	30.89%59.89M	27.91%59.67M	58.10%77.46M	58.83%76.28M	24.87%45.76M	46.33%46.65M	92.82%49M	119.77%48.03M	179.14%36.64M	169.06%31.88M
Total current assets	-19.10%378.05M	-9.35%407.3M	-4.68%430.32M	-18.95%402.15M	-11.23%467.28M	13.95%449.29M	-0.87%451.46M	9.04%496.2M	2.45%526.42M	-28.29%394.3M
Non Current assets
Long-term equity investment	-11.65%79.1M	-26.32%80.18M	-43.38%87.18M	-43.86%89.15M	-45.48%89.53M	-36.27%108.81M	-1.30%153.98M	10.66%158.82M	38.23%164.2M	70.78%170.74M
Fixed assets	----	----	----	9.26%590.08M	----	14.11%609.13M	----	29.82%540.06M	----	47.38%533.8M
Constru in process	----	----	----	-73.32%26.99M	----	-40.99%29.86M	----	-38.77%101.13M	----	-65.63%50.6M
Intangible assets	-12.56%246.28M	-13.84%251.66M	161.83%278.98M	161.29%287.81M	195.85%281.66M	189.66%292.08M	0.09%106.55M	-1.37%110.15M	-15.30%95.21M	-15.22%100.83M
Development expenditure	-93.43%411.68K	16.66%5.84M	-96.54%5.72M	-96.08%5.69M	-90.19%6.27M	-76.67%5M	685.38%165.26M	600.57%145.18M	148.95%63.88M	-15.15%21.45M
Goodwill	0.00%58.97M	0.00%58.97M	0.00%58.97M	0.00%58.97M	0.00%58.97M	0.00%58.97M	0.00%58.97M	0.00%58.97M	0.00%58.97M	0.00%58.97M
Long deferred expense	-13.58%35.66M	-13.58%36.94M	-11.34%38.56M	-7.88%39.79M	10.12%41.26M	26.57%42.75M	36.97%43.49M	98.40%43.19M	265.81%37.47M	364.14%33.77M
Deferred tax assets	-38.41%1.46M	27.13%1.47M	-95.49%2.33M	-95.31%2.37M	-97.13%2.37M	-98.37%1.15M	-0.26%51.62M	1.47%50.58M	62.35%82.57M	65.02%71.07M
Usufruct assets	-43.87%219.67K	-25.56%370.76K	41.93%521.85K	49.59%432.94K	9.53%391.38K	17.13%498.08K	202.48%367.67K	177.59%289.42K	128.48%357.33K	103.92%425.23K
Other non current assets	-50.14%8.56M	-52.40%8.06M	-73.79%8.92M	-76.21%8.43M	-75.37%17.18M	-71.23%16.94M	-30.39%34.04M	-33.58%35.44M	85.54%69.73M	74.48%58.87M
Total non current assets	-10.72%1B	-11.47%1.03B	-12.98%1.08B	-10.78%1.11B	-5.62%1.13B	5.87%1.17B	18.26%1.25B	19.46%1.24B	21.79%1.19B	22.71%1.1B
Total assets	-13.18%1.38B	-10.88%1.44B	-10.77%1.51B	-13.11%1.51B	-7.34%1.59B	8.00%1.61B	12.48%1.7B	16.29%1.74B	15.13%1.72B	3.32%1.49B
Liabilities
Current liabilities
Short term loan	-32.79%172.19M	-16.88%182.18M	6.98%229.21M	-6.78%207.23M	36.83%256.21M	4.73%219.18M	10.32%214.25M	68.24%222.31M	68.79%187.25M	169.15%209.27M
Notes payable and accounts payable	-9.91%187.92M	-5.78%213.84M	51.49%227.52M	31.46%197.44M	95.82%208.59M	139.02%226.96M	91.41%150.19M	84.41%150.2M	22.56%106.53M	11.02%94.96M
-Notes payable	----	----	71.43%600K	-57.39%600K	----	----	-89.33%350K	-62.46%1.41M	-40.53%1.56M	-20.35%1.84M
-Accounts payable	-9.91%187.92M	-5.78%213.84M	51.44%226.92M	32.30%196.84M	98.72%208.59M	143.74%226.96M	99.29%149.84M	91.50%148.79M	24.52%104.97M	11.89%93.12M
Contract liabilities	-15.19%5.66M	-70.05%3.57M	-66.39%5.1M	-27.98%6.78M	6.89%6.68M	44.81%11.91M	189.31%15.18M	68.23%9.41M	-19.78%6.25M	24.02%8.22M
Advance receipts	75.00%6.74K	0.00%5.78K	----	0.00%1.93K	0.00%3.85K	--5.78K	----	--1.93K	--3.85K	----
Salaries payable	-6.42%5.77M	-25.94%11.67M	-8.00%9.64M	-17.10%6.66M	0.44%6.17M	16.02%15.76M	19.07%10.47M	20.51%8.03M	37.38%6.14M	28.27%13.58M
Taxs payable	-6.94%6.63M	15.13%8.65M	6.56%8.22M	-6.23%6.32M	-1.39%7.12M	-55.57%7.51M	-67.35%7.71M	-67.16%6.74M	-56.61%7.22M	16.50%16.91M
Other payable (including interest and dividends)	-11.51%35.12M	-14.31%36.52M	-29.19%33.1M	-17.28%37.17M	-6.36%39.69M	-8.46%42.62M	9.01%46.74M	10.98%44.93M	-1.51%42.38M	5.90%46.56M
-Other payable	----	----	----	-17.28%37.17M	----	-8.46%42.62M	----	10.98%44.93M	----	5.90%46.56M
Non current liabilities due within one year	112.90%134.2M	63.22%118.02M	52.60%32.38M	184.93%60.4M	162.71%63.03M	298.72%72.3M	-65.46%21.22M	-65.50%21.2M	-61.65%23.99M	-71.02%18.13M
Other current liabilities	-23.77%573.66K	-78.43%326.54K	-63.83%590.83K	-8.63%809.49K	15.40%752.56K	66.29%1.51M	141.51%1.63M	51.51%885.93K	-43.19%652.14K	21.54%910.28K
Total current liabilities	-6.83%548.08M	-3.85%574.78M	16.77%545.75M	12.75%522.81M	54.63%588.25M	46.31%597.76M	12.54%467.39M	32.91%463.7M	14.07%380.42M	35.14%408.55M
Current liabilities
Long term loan	-16.01%139.71M	-15.10%142.36M	-17.66%182.64M	-23.16%169.19M	-10.25%166.34M	99.54%167.69M	562.12%221.81M	489.51%220.18M	329.52%185.34M	78.80%84.04M
Estimate liabilities	----	--1.04M	----	----	----	----	--608.24K	--608.24K	--1.26M	--1.79M
Deferred tax liabilities	11.40%2.66M	11.77%2.67M	11.35%2.36M	13.64%2.44M	4.01%2.39M	-1.36%2.38M	12.93%2.12M	11.50%2.15M	-72.30%2.3M	17.99%2.42M
Long term deferred income	68.26%65.71M	65.00%65.99M	-6.56%37.18M	-6.40%38.11M	-4.23%39.05M	-5.52%39.99M	-5.95%39.79M	-5.92%40.72M	-8.01%40.78M	-7.09%42.33M
Lease liabilities	----	----	----	----	447.44%554K	-4.76%94.87K	--50.07K	----	--101.2K	--99.61K
Other non current liabilities	7.38%259.6M	7.54%255.2M	7.69%250.7M	7.84%246.2M	7.99%241.76M	--237.31M	--232.81M	--228.31M	--223.86M	----
Total non current liabilities	3.91%467.69M	4.42%467.25M	-4.89%472.88M	-7.32%455.95M	-0.78%450.09M	242.44%447.47M	539.99%497.19M	495.94%491.96M	373.66%453.63M	38.12%130.67M
Total liabilities	-2.18%1.02B	-0.31%1.04B	5.60%1.02B	2.42%978.75M	24.49%1.04B	93.84%1.05B	95.66%964.58M	121.51%955.67M	94.29%834.06M	35.85%539.22M
Shareholders equity
Paid-in capital	0.00%159.27M	0.00%159.27M	0.00%159.27M	0.00%159.27M	0.00%159.27M	0.00%159.27M	0.00%159.27M	0.00%159.27M	0.31%159.27M	0.31%159.27M
Capital reserve funds	0.00%607.93M	0.00%607.93M	0.00%607.93M	-0.62%607.93M	-0.62%607.93M	-9.44%607.93M	-9.58%607.93M	-9.02%611.69M	-7.22%611.69M	1.82%671.32M
Surplus reserve funds	0.00%44.39M	0.00%44.39M	0.00%44.39M	0.00%44.39M	0.00%44.39M	0.00%44.39M	0.00%44.39M	0.00%44.39M	0.00%44.39M	0.00%44.39M
Retained profit	-54.93%-479.9M	-52.97%-451.41M	-156.95%-365.74M	-219.23%-331.14M	-3,053.33%-309.75M	-651.74%-295.1M	-230.11%-142.34M	-167.07%-103.73M	-105.72%-9.82M	-70.43%53.49M
Shareholders equity without minority interests	-33.91%331.69M	-30.26%360.18M	-33.38%445.84M	-32.49%480.45M	-37.70%501.84M	-44.37%516.48M	-32.08%669.25M	-30.96%711.62M	-22.11%805.53M	-11.01%928.46M
Minority interests	-32.51%35.56M	-30.63%36.6M	-21.25%49.64M	-27.57%52.68M	-33.74%52.7M	94.26%52.76M	108.89%63.04M	113.13%72.73M	168.37%79.53M	318.59%27.16M
Total shareholder equity	-33.77%367.25M	-30.30%396.78M	-32.34%495.49M	-32.03%533.12M	-37.34%554.54M	-40.43%569.24M	-27.89%732.29M	-26.34%784.35M	-16.81%885.06M	-8.97%955.62M
Total liabilityies and equity	-13.18%1.38B	-10.88%1.44B	-10.77%1.51B	-13.11%1.51B	-7.34%1.59B	8.00%1.61B	12.48%1.7B	16.29%1.74B	15.13%1.72B	3.32%1.49B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	Beijing Dehao International Accounting Firm (Special General Partnership)	--	--	--	Dahua Certified Public Accountants (Special General Partnership)	--	--	--	Dahua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

300436 Fujian Cosunter Pharmaceutical

Fujian Cosunter Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights

Discussing

Latest News

Investment Course